Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Jacquin, Jean-Philippe
PELICAN, NCT03515798 / 2016-001868-11: Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast Cancer	Active, not recruiting	2	52	Europe	Pembrolizumab Injection, MK3475, neoadjuvant EC-paclitaxel chemotherapy, Epirubicine, Cyclophosphamide, Paclitaxel	Institut Paoli-Calmettes, MSD France, Oncodistinct	Inflammatory Breast Cancer	08/22	08/27
PROFILER, NCT01774409: Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer	Recruiting	N/A	10000	Europe	Blood and tumor samples	Centre Leon Berard	Neoplasms	07/25	07/26
FAVRE, Pauline
No trials found